☆ 4.6 Article

Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Review Urology & Nephrology

Risk models for recurrence and survival after kidney cancer: a systematic review

Juliet A. Usher-Smith et al.

Summary: This study systematically compared the performance of different prognostic models in predicting survival or recurrence in patients with localized renal cell cancer who underwent surgery. The study found that several models had good discriminative ability, and there was no single "best" model. When choosing a model, both the comparative performance and the availability of factors included in the model should be considered.

BJU INTERNATIONAL (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study

Jinkui Wang et al.

Summary: The study aimed to construct a competitive risk model to predict cancer-specific survival in elderly patients with chromophobe renal cell carcinoma. The model showed good accuracy and reliability in predicting patients' survival outcomes.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Urology & Nephrology

GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study

Simon Juul et al.

Summary: This study validated the performance of the GRade, Age, Nodes, and Tumor score and Leibovich score in predicting disease recurrence in clear cell and non-clear cell renal cell carcinoma. The Leibovich score outperformed the GRade, Age, Nodes, and Tumor score in predicting recurrence-free survival and should be used as the standard approach to risk stratify patients during follow-up when all data are available.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

Add to Collection

Review Urology & Nephrology

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours

Holger Moch et al.

Summary: The fifth edition of the WHO classification of urogenital tumours has made significant revisions, including the introduction of molecular-driven renal tumour classification and simplification of the morphologic classification of penile squamous cell carcinomas. A new chapter has also been added for tumours of the scrotum. The main nomenclature for testicular tumours remains the same, but there have been changes in some terms.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Oncology

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma

Shuaishuai Li et al.

Summary: The study constructed and validated nomograms to predict postoperative overall survival and cancer-specific survival for patients with chromophobe renal cell carcinoma, showing favorable predictive power and providing guidance for prognosis and treatment.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma

Chunyang Chen et al.

Summary: This study built and tested two effective nomograms for predicting cancer-specific survival and overall survival of chromophobe renal cell carcinoma (chRCC) patients. The nomograms were validated to be highly accurate and applicable, showing higher accuracy in predicting survival outcomes when compared with traditional staging systems.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Add to Collection

Article Urology & Nephrology

Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma

Andres F. Correa et al.

Summary: This study introduces a contemporary RCC prognostic model built using prospective, highly annotated data from a clinical trial, which outperforms existing prognostic models and accurately predicts the risk of renal cell carcinoma in patients.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation

Andres F. Correa et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

Sebastiano Buti et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Urology & Nephrology

Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery

Bradley C. Leibovich et al.

EUROPEAN UROLOGY (2018)

Add to Collection

Review Oncology

Non-Clear Cell Renal Cell Carcinomas: From Shadow to Light

Laurence Albiges et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population

S. Buti et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Urology & Nephrology

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement

Gary S. Collins et al.

EUROPEAN UROLOGY (2015)

Add to Collection

Article Oncology

Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC): A Phase III, Randomized, Multicentre Trial of the Italian Oncology Group for Clinical Research (GOIRC)

Rodolfo Passalacqua et al.

JOURNAL OF IMMUNOTHERAPY (2014)

Add to Collection

Article Urology & Nephrology

The Surgical Approach to Multifocal Renal Cancers: Hereditary Syndromes, Ipsilateral Multifocality, and Bilateral Tumors

Brian Shuch et al.

UROLOGIC CLINICS OF NORTH AMERICA (2012)

Add to Collection

Article Oncology

Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram

Alexander Kutikov et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Add to Collection

Article Oncology

Multi-institutional validation of a new renal cancer-specific survival nomogram

Pierre I. Karakiewicz et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Add to Collection

Article Health Care Sciences & Services

Decision curve analysis: A novel method for evaluating prediction models

Andrew J. Vickers et al.

MEDICAL DECISION MAKING (2006)

Add to Collection

Article Biology

Survival model predictive accuracy and ROC curves

PJ Heagerty et al.

BIOMETRICS (2005)

Add to Collection

Article Oncology

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

A Zisman et al.

JOURNAL OF CLINICAL ONCOLOGY (2002)

Add to Collection

Article Urology & Nephrology

A postoperative prognostic nomogram for renal cell carcinoma

MW Kattan et al.

JOURNAL OF UROLOGY (2001)

Add to Collection

Article Oncology

Improved prognostication of renal cell carcinoma using an integrated staging system

A Zisman et al.

JOURNAL OF CLINICAL ONCOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.